Sally Waddle Mcgeehan NP

Recommended Articles

• Common Multiple Sclerosis Treatments: An Overview

  A debilitating disease that was once the face of a crushing and “hopeless” diagnosis has evolved from having one effective treatment to multiple effective treatments. Longtime sufferers who didn’t respond to one medication now have options to try others, to participate in a clinical trial or...

• What Is Porphyria?

  Porphyria is an inherited group of disorders that affect the skin and nerves. Porphyria that affects the skin is referred to as cutaneous porphyria, while the condition that affects the nerves is known as acute porphyria. Both types result in the accumulation of the chemical porphyrin in the body....

• How to Treat Pinpoint Petechiae: 21 Natural Home Remedies

  What is Petechiae?They are mostly said to be small, dark red, purple or maroon spots that tend to often develop on the skin. They are caused due to broken capillaries that often lead to subdermal or submucosal bleeding. These mostly get resolved without any kind of medical treatment and hence are...

• For People with Crohn's, Mental Well-Being Is Just as Important as Physical

  The impact of Crohn’s disease on a person’s lifestyle can be dramatic. The unpredictability of flare ups, medication reactions, and even bathroom locations puts a strain on the person’s ability to participate in everyday life. It’s challenging to make and keep plans when day-to-day symptoms...

• How to Treat Cold Sores

  Cold sores, or fever blisters, are caused by herpes simplex virus 1 and can be characterized by itchy blisters that are often very painful. It is difficult to completely cure this condition but the symptoms can be alleviated so that you don’t have to suffer unnecessarily. In most cases, the sores...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...